Search hospitals > Indiana > Indianapolis
Indiana University/Melvin and Bren Simon Cancer Center
Claim this profileIndianapolis, Indiana 46202
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Ovarian Cancer
Conducts research for Leukemia
Conducts research for Tumors
917 reported clinical trials
42 medical researchers
Summary
Indiana University/Melvin and Bren Simon Cancer Center is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Cancer, Breast Cancer, Ovarian Cancer, Leukemia, Tumors and other specialties. Indiana University/Melvin and Bren Simon Cancer Center is involved with conducting 917 clinical trials across 574 conditions. There are 42 research doctors associated with this hospital, such as Kathy Miller, MD, Nabil Adra, MD, Shadia Jalal, MD, and Anita Turk, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
HER2 positive
Top PIs
Kathy Miller, MDIndiana University/Melvin and Bren Simon Cancer Center8 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
17 reported clinical trials
55 drugs studied
Nabil Adra, MDIndiana University Melvin and Bren Simon Cancer Center4 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
15 reported clinical trials
32 drugs studied
Shadia Jalal, MDIndiana University/Melvin and Bren Simon Cancer Center9 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
11 reported clinical trials
21 drugs studied
Anita Turk, MDIndiana University/Melvin and Bren Simon Cancer Center5 years of reported clinical research
Studies Pancreatic Cancer
Studies Cancer
11 reported clinical trials
22 drugs studied
Clinical Trials running at Indiana University/Melvin and Bren Simon Cancer Center
Breast Cancer
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Germ Cell Tumors
Small Cell Lung Cancer
Lymphoma
Leukemia
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Giredestrant + Everolimus
for Advanced or Metastatic Breast Cancer
This trial is testing if a combination of giredestrant and everolimus works better than other hormone treatments plus everolimus in patients with advanced breast cancer who have already tried other treatments. The drugs work by blocking estrogen receptors and a growth pathway in cancer cells. Everolimus has been shown to improve outcomes in breast cancer patients when combined with hormonal treatments.
Recruiting2 awards Phase 37 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Indiana University/Melvin and Bren Simon Cancer Center?
Indiana University/Melvin and Bren Simon Cancer Center is a medical facility located in Indianapolis, Indiana. This center is recognized for care of Cancer, Breast Cancer, Ovarian Cancer, Leukemia, Tumors and other specialties. Indiana University/Melvin and Bren Simon Cancer Center is involved with conducting 917 clinical trials across 574 conditions. There are 42 research doctors associated with this hospital, such as Kathy Miller, MD, Nabil Adra, MD, Shadia Jalal, MD, and Anita Turk, MD.
Where is Indiana University/Melvin and Bren Simon Cancer Center located?
The Indiana University Melvin and Bren Simon Cancer Center is located at 980 W. Walnut St., Indianapolis, IN 46202. It is situated near the intersection of West Walnut Street and Senate Avenue, within the IU Health campus in downtown Indianapolis.
Who should I call to ask about financial aid or insurance network?
**Indiana University/Melvin and Bren Simon Cancer Center Financial Assistance:**
- **Phone:** (877) 846-3448
- **Website:** [IU Health Financial Assistance](https://www.indianadisabilityresourcefinder.org/view/provider/2646/iu-health-financial-assistance)
**Insurance Department:**
- **Website:** [Contact Information](https://cancer.iu.edu/contact/index.html)
For additional support, refer to the IU Cancer Support Resource Guide for Indiana University Employees.
What insurance does Indiana University/Melvin and Bren Simon Cancer Center accept?
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center, located in Indianapolis, Indiana, is Indiana's only National Cancer Institute-designated comprehensive cancer center. It offers a multidisciplinary approach to patient care, combining treatment, research, and supportive care tailored to individual needs. The center is recognized for its significant contributions to cancer research, including over 700 adult and pediatric clinical trials, and its commitment to improving patient outcomes through innovative therapies and comprehensive care programs like the CompleteLife Program.
What awards or recognition has Indiana University/Melvin and Bren Simon Cancer Center received?
The Indiana University Melvin and Bren Simon Comprehensive Cancer Center is Indiana's only National Cancer Institute-designated comprehensive cancer center, a distinction that represents the highest level of recognition from the National Cancer Institute. It has earned international acclaim for its pioneering clinical and novel cancer research, supported by nearly 250 dedicated researchers. Through a partnership with IU Health, Indiana's largest health system, the center's physician-scientists extend their expertise across the state, influencing care at all 16 IU Health hospitals.